Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies C. Florin PopIsabelle VeysGabriel Liberale Review Open access 06 January 2024 Pages: 429 - 442
The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysis Deniz Can GuvenTaha Koray Sahin Review Open access 19 January 2024 Pages: 443 - 452
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma Saki NakagawaMinoru MiyashitaTakanori Ishida Preclinical study Open access 05 January 2024 Pages: 453 - 463
Reciprocal regulation of forkhead box C1 and L1 cell adhesion molecule contributes to triple-negative breast cancer progression Fan ZhangYue XuYukun Cui Preclinical study Open access 06 January 2024 Pages: 465 - 474
Integrated analysis of diverse cancer types reveals a breast cancer-specific serum miRNA biomarker through relative expression orderings analysis Liyuan MaYaru GaoHongdong Li Preclinical study Open access 08 January 2024 Pages: 475 - 484
Effectiveness and toxicity of five-fraction prone accelerated partial breast irradiation Camille Hardy-AbeloosJulie XiaoNaamit Gerber Clinical trial 06 January 2024 Pages: 485 - 495
Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcome Annemiek van HemertAriane A. van LoevezijnIris M. C. van der Ploeg Clinical trial 08 January 2024 Pages: 497 - 507
Characterizing attitudes related to future child-bearing in young women diagnosed with early-stage breast cancer Saumya UmashankarMoming LiA. Jo Chien Clinical trial Open access 09 January 2024 Pages: 509 - 520
The anti-proliferative effects of a frankincense extract in a window of opportunity phase ia clinical trial for patients with breast cancer Ingrid V. Bonilla ValenteDenise GarciaNancy Klauber-DeMore Clinical trial Open access 09 January 2024 Pages: 521 - 530
The COVID-19 pandemic and its effects on follow-up of patients with early breast cancer: A patient survey Ana-Alicia Beltran-BlessGail LarocqueMark Clemons Clinical trial 09 January 2024 Pages: 531 - 538
Polypharmacy, over-the-counter medications, and aromatase inhibitor adherence in early-stage breast cancer Elizabeth JoyceXueting TaoN. Lynn Henry Clinical trial 10 January 2024 Pages: 539 - 546
Identification of patient subgroups who benefit from a behavioral intervention to improve adjuvant endocrine therapy adherence: a randomized-controlled trial Emily A. WalshKathryn PostJamie M. Jacobs Clinical trial 17 January 2024 Pages: 547 - 559
Association between trajectories of prescription opioid use and risk of opioid use disorder and overdose among US nonmetastatic breast cancer survivors Ching-Yuan ChangBobby L. JonesWei-Hsuan Lo-Ciganic Epidemiology 08 January 2024 Pages: 561 - 577
Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database Stephanie H. ReadNadia QuignotFrancois-Clement Bidard Epidemiology Open access 11 January 2024 Pages: 579 - 588
Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial Haiyun WangDouglas YeeAnne Blaes Epidemiology Open access 12 January 2024 Pages: 589 - 597
Factors influencing the first and the fifth years adherence to adjuvant endocrine therapy in breast cancer patients in a low income country Antonio Pedro NicolettiAndrea P Damin Epidemiology 15 January 2024 Pages: 599 - 606
Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer Maria Eleni HatzipanagiotouMiriam PigerlStephan Seitz Epidemiology Open access 19 January 2024 Pages: 607 - 615
Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer Jianxin ZhongHanfang JiangHuiping Li Original Laboratory Investigation Open access 06 January 2024 Pages: 617 - 629
Endosomal recycling inhibitors downregulate estrogen receptor-alpha and synergise with endocrine therapies Kelsey A. FletcherMai H. AlkurashiAndrew J. Lindsay Original Laboratory Investigation Open access 16 January 2024 Pages: 631 - 642
Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors Alexander S. BangChristopher J. FayBernice Y. Kwong Brief Communication 15 January 2024 Pages: 643 - 647
